Back

C Suite Market Update - February 2014

February 2014

CEO and CFO changes within corporates are down from February 2013 as well as in decline over last month. However overall C level turnover for the month was static as compared to a year ago, yet saw a decline over Jan. 2014 numbers. Board of Director turnover saw only minor declines both from last month and last year.

Declines in Feb. 2014 (from 02/2013) were in three key areas:

  • CEO changes, -19%   A total of 168 changes with the largest number of changes occurring in energy, manufacturing and consumer products
  • CFO changes,  - 9%   A total of 147 changes with the largest number of changes occurring in drugs/biotech, health services and telecom
  • Board of Directors,  - 3%   A total of 430 changes with the largest number of changes occurring in drugs/biotech, energy and banking
  • Overall C suite, number of changes remained static.  A total of 1279 changes with the largest number of changes occurring in drugs/biotech, energy and banking

January to February 2014 showed no change in turnover for CEO’s whereas declines of 5% and 12% were realized for CFO’s and C levels respectively. Board of Director changes declined by just 1%.